Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
Sales | 10,984,000 | 10,867,000 | 12,346,000 | 11,973,000 | 12,129,000 |
Cost of Goods | 1,756,000 | 1,408,000 | 1,715,000 | 2,122,000 | 2,289,000 |
Gross Profit | 9,228,000 | 9,459,000 | 10,631,000 | 9,851,000 | 9,840,000 |
Operating Expenses | 6,107,000 | 5,713,000 | 8,195,000 | 6,408,000 | 7,217,000 |
Operating Income | 3,121,000 | 3,746,000 | 2,436,000 | 3,443,000 | 2,623,000 |
Other Income | -72,000 | 57,000 | -1,811,000 | -721,000 | 167,000 |
Pre-tax Income | 3,049,000 | 3,803,000 | 625,000 | 2,722,000 | 2,790,000 |
Income Tax | 786,000 | 1,074,000 | 394,000 | 463,000 | 25,000 |
Net Income Continuous | 2,263,000 | 2,729,000 | 231,000 | 2,259,000 | 2,765,000 |
Net Income Discontinuous | 3,000 | 1,000 | 40,000 | 25,000 | 17,000 |
Minority Interests | 5,000 | 1,000 | 5,000 | 6,000 | 6,000 |
Net Income | $2,261,000 | $2,729,000 | $266,000 | $2,278,000 | $2,776,000 |
EPS Basic Total Ops | 0.34 | 0.41 | 0.04 | 0.34 | 0.41 |
EPS Basic Continuous Ops | 0.34 | 0.41 | 0.03 | 0.34 | 0.41 |
EPS Diluted Total Ops | 0.34 | 0.40 | 0.04 | 0.34 | 0.41 |
EPS Diluted Continuous Ops | 0.34 | 0.40 | 0.04 | 0.33 | 0.41 |
EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
EBITDA(a) | $4,127,000 | $4,754,000 | $3,614,000 | $4,639,000 | $3,852,000 |